Peripheral cancer attenuates amyloid pathology in Alzheimer’s disease via cystatin-c activation of TREM2

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

Lecanemab in early Alzheimer's disease

van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678 · see citing works

Alzheimer's disease

Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465 · see citing works

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · see citing works

<i>TREM2</i> Variants in Alzheimer's Disease

Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · see citing works

Tau in physiology and pathology

Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251 · see citing works

Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · see citing works

Amyloid Precursor Protein Processing and Alzheimer's Disease

O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061 · see citing works

Genetic enhancement of learning and memory in mice

Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,867 · see citing works

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728 · see citing works

Donanemab in Early Alzheimer’s Disease

Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100708 · Cited by 1,728 · see citing works

Alzheimer’s Disease: The Challenge of the Second Century

Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424 · see citing works

Gamma frequency entrainment attenuates amyloid load and modifies microglia

Iaccarino, H. F., Singer, A. C., Martorell, A. J., Rudenko, A., Gao, F., Gillingham, T. Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. (2016) · Nature · doi:10.1038/nature20587 · Cited by 1,328 · see citing works

APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline

Montagne, A., Nation, D. A., Sagare, A. P., Barisano, G., Sweeney, M. D., Chakhoyan, A., Pachicano, M., Joe, E., Nelson, A. R., D’Orazio, L. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2247-3 · Cited by 1,281 · see citing works

The ADAM metalloproteinases

Edwards, D. R., Handsley, M. M., & Pennington, C. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.001 · Cited by 1,165 · see citing works

Role of tau protein in both physiological and pathological conditions

AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · see citing works

Roles of tau protein in health and disease

Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003 · see citing works

Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future

Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988 · see citing works

TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia

Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943 · see citing works

TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function

Zhao, Y., Wu, X., Li, X., Jiang, L.-L., Gui, X., Liu, Y., Sun, Y., Zhu, B., Piña-Crespo, J. C., Zhang, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.031 · Cited by 763 · see citing works

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744 · see citing works

Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)

Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702 · see citing works

TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models

Jay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · see citing works

Cancer neuroscience: State of the field, emerging directions

Winkler, F., Venkatesh, H. S., Amit, M., Batchelor, T. T., Demir, İ. E., Deneen, B., Gutmann, D. H., Hervey‐Jumper, S. L., Kuner, T., Mabbott, D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.002 · Cited by 578 · see citing works

β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer

Renz, B. W., Takahashi, R., Tanaka, T., Macchini, M., Hayakawa, Y., Dantes, Z., Maurer, H. C., Chen, X., Jiang, Z., Westphalen, C. B., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.11.007 · Cited by 543 · see citing works

Meta-hallmarks of aging and cancer

López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529 · see citing works

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513 · see citing works

LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease

Heckmann, B. L., Teubner, B. J. W., Tummers, B., Boada-Romero, E., Harris, L., Yang, M., Guy, C. S., Zakharenko, S. S., & Green, D. R. (2019) · Cell · doi:10.1016/j.cell.2019.05.056 · Cited by 503 · see citing works

TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways

Wang, S., Sudan, R., Peng, V., Zhou, Y., Du, S., Yuede, C. M., Lei, T., Hou, J., Cai, Z., Cella, M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.033 · Cited by 471 · see citing works

Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease

Söderberg, L., Johannesson, M., Nygren, P., Laudon, H., Eriksson, F., Osswald, G., Möller, C., & Lannfelt, L. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01308-6 · Cited by 444 · see citing works

Alzheimer's disease and Aβ toxicity: from top to bottom

Small, D. H., Mok, S. S., & Bornstein, J. C. (2001) · Nature reviews. Neuroscience · doi:10.1038/35086072 · Cited by 390 · see citing works

The neuroscience of cancer

Mancusi, R. A., & Monje, M. (2023) · Nature · doi:10.1038/s41586-023-05968-y · Cited by 370 · see citing works

Progenitors from the central nervous system drive neurogenesis in cancer

Mauffrey, P., Tchitchek, N., Barroca, V., Bemelmans, A., Firlej, V., Allory, Y., Roméo, P., & Magnon, C. (2019) · Nature · doi:10.1038/s41586-019-1219-y · Cited by 356 · see citing works

Plaque formation and the intraneuronal accumulation of β‐amyloid in Alzheimer's disease

Takahashi, R. H., Nagao, T., & Gouras, G. K. (2017) · Pathology International · doi:10.1111/pin.12520 · Cited by 354 · see citing works

TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury

Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Trümbach, D., Wurst, W., et al. (2017) · The EMBO Reports · doi:10.15252/embr.201743922 · Cited by 351 · see citing works

Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease

Gouras, G. K., Almeida, C. G., & Takahashi, R. H. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.022 · Cited by 338 · see citing works

Cancer hallmarks intersect with neuroscience in the tumor microenvironment

Hanahan, D., & Monje, M. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.012 · Cited by 325 · see citing works

Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease

Thal, D. R., Walter, J., Saido, T. C., & Fändrich, M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1375-y · Cited by 319 · see citing works

Biochemistry and Clinical Role of Human Cystatin C

Mussap, M., & Plebani, M. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490504934 · Cited by 316 · see citing works

Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2

Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302 · see citing works

BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice

Ohno, M., Cole, S. L., Yasvoina, M., Zhao, J., Citron, M., Berry, R., Disterhoft, J. F., & Vassar, R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.008 · Cited by 290 · see citing works

Activation of Wnt/β-catenin pathway mitigates blood–brain barrier dysfunction in Alzheimer’s disease

Wang, Q., Huang, X., Su, Y., Yin, G., Wang, S., Yu, B., Li, H., Qi, J., Chen, H., Zeng, W., et al. (2022) · Brain · doi:10.1093/brain/awac236 · Cited by 219 · see citing works

Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis

Kim, J., Jiang, H., Park, S., Eltorai, A. E. M., Stewart, F. R., Yoon, H., Basak, J. M., Finn, M. B., & Holtzman, D. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3773-11.2011 · Cited by 199 · see citing works

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

Sunderland, T., Mirza, N., Putnam, K. T., Linker, G., Bhupali, D., Durham, R., Soares, H., Kimmel, L., Friedman, D., Bergeson, J., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.021 · Cited by 179 · see citing works

Cystatin C modulates cerebral β-amyloidosis

Kaeser, S. A., Herzig, M. C., Coomaraswamy, J., Kilger, E., Selenica, M. B., Winkler, D. T., Staufenbiel, M., Levy, E., GRUBB, A. O., & Jucker, M. (2007) · Nature Genetics · doi:10.1038/ng.2007.23 · Cited by 172 · see citing works

Cystatin Superfamily

Ochieng, J., & Chaudhuri, G. (2010) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.0.0257 · Cited by 161 · see citing works

Cerebrovascular pathology during the progression of experimental Alzheimer's disease

Giannoni, P., Arango-Lievano, M., das Neves, I., Rousset, M.-C., Baranger, K., Rivera, S., Jeanneteau, F. D., Claeysen, S., & Marchi, N. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.001 · Cited by 146 · see citing works

Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading

Jain, N., Lewis, C. A., Ulrich, J. D., & Holtzman, D. M. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20220654 · Cited by 146 · see citing works

Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer’s disease

Ellwanger, D. C., Wang, S., Brioschi, S., Shao, Z., Green, L. B., Case, R. B., Yoo, D., Weishuhn, D., Rathanaswami, P., Bradley, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017742118 · Cited by 143 · see citing works

Cystatin C in aging and in Alzheimer’s disease

Mathews, P. M., & Levy, E. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.003 · Cited by 133 · see citing works

Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?

Pivovarova‐Ramich, O., Höhn, A., Grune, T., Pfeiffer, A. F. H., & Rudovich, N. N. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1197416 · Cited by 132 · see citing works

Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways

Lanni, C., Masi, M., Racchi, M., & Govoni, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0760-2 · Cited by 130 · see citing works

Association Between Alzheimer Disease and Cancer With Evaluation of Study Biases: A Systematic Review and Meta-analysis

Ospina-Romero, M., Glymour, M. M., Hayes-Larson, E., Mayeda, E. R., Graff, R. E., Brenowitz, W. D., Ackley, S. F., Witte, J. S., & Kobayashi, L. C. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.25515 · Cited by 124 · see citing works

Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease

Schlepckow, K., Morenas‐Rodríguez, E., Hong, S. Y., & Haass, C. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00247-8 · Cited by 121 · see citing works

Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates A production

Vagnoni, A., Perkinton, M. S., Gray, E. H., Francis, P. T., Noble, W. J., & Miller, C. C. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds109 · Cited by 117 · see citing works

Association of cancer and Alzheimer's disease risk in a national cohort of veterans

Frain, L., Swanson, D., Cho, K., Gagnon, D., Lu, K. P., Betensky, R. A., & Driver, J. (2017) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2017.04.012 · Cited by 115 · see citing works

A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.

Neumann, U., Rueeger, H., Machauer, R., Veenstra, S. J., Lueoend, R. M., Tintelnot-Blomley, M., Laue, G., Beltz, K., Vogg, B., Schmid, P., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0033-8 · Cited by 113 · see citing works

Molecular mechanisms that underlie structural and functional changes atthe postsynaptic membrane duringsynaptic plasticity

Wheal, H. V., Chen, Y., Mitchell, J., Schachner, M., Maerz, W., Wieland, H., van Rossum, D., & Kirsch, J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00026-4 · Cited by 93 · see citing works

Intraneuronal Aβ accumulation and neurodegeneration: Lessons from transgenic models

Wirths, O., & Bayer, T. A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.001 · Cited by 91 · see citing works

Myelin changes at the early stage of 5XFAD mice

Gu, L., Wu, D., Tang, X., Qi, X., Li, X., Bai, F., Chen, X., Ren, Q., & Zhang, Z. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.12.013 · Cited by 87 · see citing works

Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels

Bekris, L. M., Millard, S. P., Galloway, N. M., Vuletic, S., Albers, J. J., Li, G., Galasko, D. R., DeCarli, C., Farlow, M. R., Clark, C. M., et al. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13303 · Cited by 85 · see citing works

β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer’s disease model mice

Zhao, Y., Zheng, Q., Hong, Y., Gao, Y., Hu, J., Lang, M., Zhang, H., Zhou, Y., Luo, H., Zhang, X., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01352-1 · Cited by 84 · see citing works

Serotonin receptor 2c-expressing cells in the ventral CA1 control attention via innervation of the Edinger–Westphal nucleus

Li, X., Chen, W., Pan, K., Li, H., Pang, P., Guo, Y., Shu, S., Cai, Y., Pei, L., Liu, D., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0207-0 · Cited by 83 · see citing works

Associations between cancer and Alzheimer's disease in a U.S. Medicare population

Freedman, D. M., Wu, J., Chen, H., Kuncl, R. W., Enewold, L., Engels, E. A., Freedman, N. D., & Pfeiffer, R. M. (2016) · Cancer Medicine · doi:10.1002/cam4.850 · Cited by 75 · see citing works

Inverse Correlation Between Alzheimer’s Disease and Cancer: Short Overview

Zabłocka, A., Kazana, W., Sochocka, M., Stańczykiewicz, B., Janusz, M., Leszek, J., & Orzechowska, B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02544-1 · Cited by 73 · see citing works

The amyloid precursor protein (APP) processing as a biological link between Alzheimer’s disease and cancer

Galvão, F., Grokoski, K. C., da Silva, B. B., Lamers, M. L., & Siqueira, I. R. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.007 · Cited by 66 · see citing works

Synthesis and metabolism of methylglyoxal, S-D-lactoylglutathione and D-lactate in cancer and Alzheimer’s disease. Exploring the crossroad of eternal youth and premature aging

Lidia de, B. A. R. I., Atlante, A., Armeni, T., & Kalapos, M. P. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100915 · Cited by 66 · see citing works

<scp>LINGO</scp>‐1 antibody ameliorates myelin impairment and spatial memory deficits in the early stage of 5<scp>XFAD</scp> mice

Wu, D., Tang, X., Gu, L., Li, X., Qi, X., Bai, F., Chen, X., Wang, J., Ren, Q., & Zhang, Z. (2018) · CNS Neuroscience &amp; Therapeutics · doi:10.1111/cns.12809 · Cited by 64 · see citing works

Multiple cancer cell types release LIF and Gal3 to hijack neural signals

Xu, Q., Cao, Y., Kong, F., Liu, J., Chen, X., Zhao, Y., Lai, C., Zhou, X., Hu, H., Fu, W., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00946-z · Cited by 61 · see citing works

Molecularly defined and functionally distinct cholinergic subnetworks

Li, X., Yu, H., Zhang, B., Li, L., Chen, W., Yu, Q., Huang, X., Xiao, K., Wang, Y., Jing, W., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.08.025 · Cited by 58 · see citing works

Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice

Bai, N., Li, N., Cheng, R., Guan, Y., Zhao, X., Song, Z., Xu, H., Yi, F., Jiang, B., Li, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111062 · Cited by 56 · see citing works

Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer’s Disease

Yang, Y., Bagyinszky, E., & An, S. S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098417 · Cited by 56 · see citing works

Specific Eph receptor-cytoplasmic effector signaling mediated by SAM–SAM domain interactions

Wang, Y., Shang, Y., Li, J., et al. (2018) · eLife · doi:10.7554/elife.35677 · Cited by 52 · see citing works

Secretory Sorting Receptors Carboxypeptidase E and Secretogranin III in Amyloid β‐Associated Neural Degeneration in A lzheimer's Disease

Plá, V., Paco, S., Ghézali, G., Ciria, V., Pozas, E., Ferrer, I., & Aguado, F. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00644.x · Cited by 50 · see citing works

Interaction between Oligomers of Stefin B and Amyloid-β in Vitro and in Cells

Škerget, K., Taler‐Verčič, A., Bavdek, A., Hodnik, V., Čeru, S., Tušek‐Žnidarič, M., Kumm, T., Pitsi, D., Pompe‐Novak, M., Palumaa, P., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024620 · Cited by 44 · see citing works

Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer’s-type neuropathology

Karanth, S. D., Katsumata, Y., Nelson, P. T., Fardo, D. W., McDowell, J. K., Schmitt, F. A., Kryscio, R. J., Browning, S. R., Braithwaite, D., Arnold, S. M., et al. (2022) · Brain · doi:10.1093/brain/awac035 · Cited by 41 · see citing works

A circuit of mossy cells controls the efficacy of memory retrieval by Gria2I inhibition of Gria2

Li, X., Chen, W., Yu, Q., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108741 · Cited by 37 · see citing works

Non-melanoma skin cancer and risk of Alzheimer’s disease and all-cause dementia

Schmidt, S. A. J., Ording, A. G., Horváth–Puhó, E., Sørensen, H. T., & Henderson, V. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171527 · Cited by 36 · see citing works

Investigating the association between cancer and dementia risk: a longitudinal cohort study

Zhang, D., Ou, Y., Liu, Y., Ma, Y., Tan, L., Feng, J., Cheng, W., & Yu, J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01090-9 · Cited by 36 · see citing works

Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid

Perlenfein, T. J., Mehlhoff, J. D., & Murphy, R. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.786558 · Cited by 31 · see citing works

Regulation of glial development by cystatin C

Hasegawa, A., Naruse, M., Hitoshi, S., Iwasaki, Y., Takebayashi, H., & Ikenaka, K. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04169.x · Cited by 30 · see citing works

Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile

Liu, P., Paulson, J. B., Forster, C. L., Shapiro, S. L., Ashe, K. H., & Zahs, K. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126317 · Cited by 28 · see citing works

Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells

Wang, X.-F., Liu, D.-X., Liang, Y., Xing, L.-L., Zhao, W.-H., Qin, X.-X., Shang, D.-S., Li, B., Fang, W.-G., Cao, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161093 · Cited by 24 · see citing works

BACE-1 Inhibitors Targeting Alzheimer's Disease

Monteiro, K. L. C., Alcântara, M. G. D. S., Freire, N. M. L., Brandão, E. M., do Nascimento, V. L., Viana, L. M. D. S., de Aquino, T. M., & da Silva‐Júnior, E. F. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230612155953 · Cited by 23 · see citing works

Presenilin Mutation Suppresses Lung Tumorigenesis via Inhibition of Peroxiredoxin 6 Activity and Expression

Park, M. H., Yun, H., Hwang, C. J., Park, S. I., Han, S., Hwang, D. Y., Yoon, D., Kim, S., & Hong, J. T. (2017) · Theranostics · doi:10.7150/thno.21408 · Cited by 22 · see citing works

Synaptic dysfunction of Aldh1a1 neurons in the ventral tegmental area causes impulsive behaviors

Li, X., Chen, W., Huang, X., Jing, W., Zhang, T., Yu, Q., Yu, H., Li, H., Tian, Q., Ding, Y., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00494-9 · Cited by 20 · see citing works

Potential Therapeutic Implications of Gelsolin in Alzheimer's Disease

Ji, L., Zhao, X., & Hua, Z. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141548 · Cited by 19 · see citing works

Terahertz Irradiation Improves Cognitive Impairments and Attenuates Alzheimer’s Neuropathology in the APPSWE/PS1DE9 Mouse: A Novel Therapeutic Intervention for Alzheimer’s Disease

Zhang, J., Chen, Y., Zhao, Y., Wang, P., Ding, H., Liu, C., Lyu, J., & Le, W. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01145-3 · Cited by 19 · see citing works

Amyloid‐β is a cytokine

Weaver, D. F. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13165 · Cited by 17 · see citing works

Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer’s disease mouse model

Lau, S., Wu, W., Seo, H., Fu, A. K. Y., & Ip, N. Y. (2021) · STAR Protocols · doi:10.1016/j.xpro.2020.100265 · Cited by 17 · see citing works

Monocytes release cystatin F dimer to associate with Aβ and aggravate amyloid pathology and cognitive deficits in Alzheimer’s disease

Li, Q., Li, B., Liu, L., Wang, K.-J., Liu, M., Deng, Y., Li, Z., Zhao, W., Wu, L., Chen, Y., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03119-2 · Cited by 15 · see citing works

Special Focus Issue Part II: Recruitment of Solid Lipid Nanoparticles for The Delivery of CRISPR/Cas9: Primary Evaluation of Anticancer Gene Editing

Akbaba, H., Erel‐Akbaba, G., & Şentürk, Ş. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0412 · Cited by 14 · see citing works

Cancer and Aging: A Complex Biological Association

Navarrete‐Reyes, A. P., Soto‐Pérez‐de‐Celis, E., & Hurria, A. (2016) · Revista de investigaci�n Cl�nica · doi:10.1016/s0034-8376(25)00203-7 · Cited by 13 · see citing works

Trem2 Enhances Demyelination in the Csf1r+/− Mouse Model of Leukoencephalopathy

Biundo, F., Chiţu, V., Gökhan, Ş., Chen, E., Oppong‐Asare, J., & Stanley, E. R. (2023) · Biomedicines · doi:10.3390/biomedicines11082094 · Cited by 8 · see citing works

Development of an immunoassay for the detection of cystatin C dimers

Hyytiä, H., Ristiniemi, N., Airas, L. M., et al. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.02.014 · Cited by 3 · see citing works

Circulating cystatin‐C is associated with dementia in a racial and ethnically diverse cohort: An interaction decomposition analysis

Tejera, C. H., Ware, E. B., Hicken, M. T., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.053278 · Cited by 1 · see citing works

Tumor-derived cystatin C enables amyloid clearance

Zambelas, J., Huang, Y., Zhao, H., & Wong, S. T. C. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.02.007 · Cited by 1 · see citing works